Tirazone (Cervical Cancer) ' Analysis and Forecasts to 2020

Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!

Tirazone (Cervical Cancer) ' Analysis and Forecasts to 2020
Published on October 2011

Report Summary


Summary

GlobalData's pharmaceuticals report, ' Tirazone ( Cervical Cancer) - Analysis and Forecasts to 2020' provides Tirazone sales
forecasts for the US. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive
landscape, and analysis of sales performance during the forecast period (2012-2020). The report also includes information on
Cervical Cancer market. This report is built using data and information sourced from GlobalData's proprietary databases, primary and
secondary research using Company's corporate website, SEC filings, investor presentations and featured press releases, both from
company and industry-specific third party sources, put together with in-house analysis, by GlobalData's team of industry experts.

Note: This is a on-demand report and will be delivered within 7 business days (excluding weekends) of the purchase.

Scope

- Therapy area profile including patient population for the US, EU5 and Japan (seven major markets)
- Analysis and review of Tirazone including sales data
- Qualitative and quantitative assessment of market space
- Analysis of the trends, drivers and restraints shaping and defining the markets
- In-depth analysis of Tirazone including efficacy, safety, pricing, competition and other details which influence its sales potential
- Detailed sales forecasts for 2012-2020 for Tirazone in the US

Reasons to buy

- Understand and capitalize by identifying products that are most likely to ensure a robust return
- Stay ahead of competition by understanding the changing competitive landscape
- Effectively plan your M&A and partnership strategies by identifying drugs with the most promising sales potential
- Make more informed business decisions from insightful and in-depth analysis of the drug's performance
- Examine the historical sales performance of a drug in seven major markets
- Obtain sales forecast for currently marketed/pipeline drug for 2011-2020 for all seven major markets

Table of Content

1 Table of contents 2
1.1 List of Tables 2
1.2 List of Figures 3
2 Introduction 4
2.1 Cervical Cancer Market 4

Tirazone (Cervical Cancer) ' Analysis and Forecasts to 2020 (From Slideshare) Page 1/5


2.2 Epidemiology 4
2.3 Etiology 6
2.3.1 HPV Infections 6
2.3.2 Lack of Regular Papanicolaou (pap) Tests 6
2.3.3 Smoking 6
2.3.4 Sexual History 6
2.3.5 Birth Control Pills 6
2.4 GlobalData Pipeline Report Guidance 7
3 Cervical Cancer Disease: Market Characterization 8
3.1 Cervical Cancer Disease Market 8
3.2 Cervical Cancer Disease Market Forecasts and CAGR 8
3.3 Drivers and Barriers for the Cervical Cancer Market 9
4 Tumor-Node-Metastases (TNM) Classification of Cervical Cancer 10
5 Tirazone (tirapazamine) 13
5.1 Introduction 13
5.2 Mechanism of Action 13
5.3 Clinical Studies 13
5.4 Factors Affecting Sales of Tirazone 14
5.4.1 High Efficacy 14
5.4.2 Competition 14
5.4.3 Marketing Rights 14
5.5 Drug Risk Benefit Score 14
5.5.1 Efficacy 15
5.5.2 Safety 15
5.5.3 Compliance 15
5.5.4 Dosing Convenience 15
5.6 Intensity of Competition 15
5.7 Sales forecast 15
5.7.1 Target patient Pool of Tirazone 15
5.7.2 Dosing 16
5.7.3 Market Penetration 16
5.7.4 Annual Cost of Therapy 16
5.7.5 Sales Projections of Tirazone 16
6 Cervical Cancer Market: Appendix 18
6.1 Market Definitions 18
6.2 Abbreviations 18
6.3 Research Methodology 18
6.3.1 Coverage 19
6.3.2 Secondary Research 19
6.3.3 Forecasting 19
6.3.4 Number of Patients Approved to take the Drug 20
6.3.5 Net Penetration of Drug 20
6.3.6 Net Annual Dosing 21
6.3.7 Annual Cost of Therapy 21
6.3.8 Primary Research 21
6.3.9 Expert Panels 21
6.4 Contact Us 22
6.5 Disclaimer 22



6.6 Sources 22

1.1 List of Tables

Table 1: Cervical Cancer, Incidences and Mortality, 2008'2030 5
Table 2: Cervical Cancer, US,EU-5 and Japan, Market Size Forecast ($m), 2009'2020 8
Table 3: Drug Risk Benefit Score of Tirazone 15
Table 4: Tirazone, Cervical Cancer, The US, Sales Forecast ($m), 2012'2020 17

1.2 List of Figures

Figure 1: Distribution of Incidence and Mortality of Top 26 Diagnosed Cancers, Global, 2010 4
Figure 2: Difference Between Percentage Distribution of Incidence and Mortality of Top 19 Cancers, 2008 5
Figure 3: Cervical Cancer, US,EU-5 and Japan, Market Size Forecast ($m), 2009'2020 8
Figure 4: Classification of Cervical Cancer 10
Figure 5: TNM Staging Classification 12
Figure 6: Classification of Cervical Cancer 12
Figure 7: Drug Model Diagram of Tirazone 16
Figure 8: Tirazone, Cervical Cancer, The US, Sales Forecast ($m), 2012'2020 17
Figure 9: GlobalData Methodology 18
Figure 10: Drug Model Diagram 20
Figure 11: Patients Approved for the Drug 21


Fax Order Form
To place an order via fax simply print this form, fill in the information below and fax the completed form to:
Europe, Middle East and Africa : + 33 4 37 37 15 56
Asia, Oceania and America : + 1 (805) 617 17 93
If you have any questions please visit http://www.reportlinker.com/notify/contact

Order Information
Please verify that the product information is correct and select the format(s) you require.


Product Formats
Please select the product formats and the quantity you require.

1 User License--USD 2 000.00 Quantity: _____

Site License--USD 4 000.00 Quantity: _____

Corporate License--USD 6 000.00 Quantity: _____

Contact Information
Please enter all the information below in BLOCK CAPITALS

Title: Mr Mrs Dr Miss Ms Prof

First Name: _____________________________ Last Name: __________________________________

Email Address: __________________________________________________________________________

Job Title: __________________________________________________________________________

Organization: __________________________________________________________________________

Address: __________________________________________________________________________

City: __________________________________________________________________________

Postal / Zip Code: __________________________________________________________________________

Country: __________________________________________________________________________

Phone Number: __________________________________________________________________________

Fax Number: __________________________________________________________________________


Payment Information
Please indicate the payment method, you would like to use by selecting the appropriate box.

Payment by credit card Card Number: ______________________________________________

Expiry Date __________ / _________

CVV Number _____________________

Card Type (ex: Visa, Amex…) _________________________________

Payment by wire transfer Crédit Mutuel
RIB : 10278 07314 00020257701 89
BIC : CMCIFR2A
IBAN : FR76 1027 8073 1400 0202 5770 189

Payment by check UBIQUICK SAS
16 rue Grenette – 69002 LYON, FRANCE

Customer signature:

Please note that by ordering from Reportlinker you are agreeing to our Terms and Conditions at
http://www.reportlinker.com/index/terms

Please fax this form to:

Europe, Middle East and Africa : + 33 4 37 37 15 56

Asia, Oceania and America : + 1 (805) 617 17 93


Tirazone (Cervical Cancer) ' Analysis and Forecasts to 2020

Recomendados

Recomendados

Mais conteúdo relacionado

Mais de ReportLinker.com

Mais de ReportLinker.com (20)

Tirazone (Cervical Cancer) ' Analysis and Forecasts to 2020